4.4 Article Proceedings Paper

Pathogenic cascades in lysosomal disease-Why so complex?

Journal

JOURNAL OF INHERITED METABOLIC DISEASE
Volume 32, Issue 2, Pages 181-189

Publisher

WILEY
DOI: 10.1007/s10545-008-1040-5

Keywords

-

Funding

  1. NICHD NIH HHS [HD045561, R01 HD045561-04, R01 HD045561] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS053677-03, NS053677, R01 NS053677] Funding Source: Medline

Ask authors/readers for more resources

Lysosomal disease represents a large group of more than 50 clinically recognized conditions resulting from inborn errors of metabolism affecting the organelle known as the lysosome. The lysosome is an integral part of the larger endosomal/lysosomal system, and is closely allied with the ubiquitin-proteosomal and autophagosomal systems, which together comprise essential cell machinery for substrate degradation and recycling, homeostatic control, and signalling. More than two-thirds of lysosomal diseases affect the brain, with neurons appearing particularly vulnerable to lysosomal compromise and showing diverse consequences ranging from specific axonal and dendritic abnormalities to neuron death. While failure of lysosomal function characteristically leads to lysosomal storage, new studies argue that lysosomal diseases may also be appropriately viewed as 'states of deficiency' rather than simply overabundance (storage). Interference with signalling events and salvage processing normally controlled by the endosomal/lysosomal system may represent key mechanisms accounting for the inherent complexity of lysosomal disorders. Analysis of lysosomal disease pathogenesis provides a unique window through which to observe the importance of the greater lysosomal system for normal cell health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available